Drug Type Small molecule drug |
Synonyms Choline fenofibrate (USAN/INN), HEXA, ABT-335 + [7] |
Target |
Action agonists |
Mechanism PPARα agonists(Peroxisome proliferator-activated receptor α agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (15 Dec 2008), |
Regulation- |
Molecular FormulaC22H28ClNO5 |
InChIKeyJWAZHODZSADEHB-UHFFFAOYSA-M |
CAS Registry856676-23-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dyslipidemias | United States | 15 Dec 2008 | |
Hyperlipidemias | United States | 15 Dec 2008 | |
Hypertriglyceridemia | United States | 15 Dec 2008 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Coronary Artery Disease | Phase 3 | United States | 01 Feb 2008 | |
Hyperlipidemia, Familial Combined | Phase 3 | United States | 01 Feb 2008 | |
Coronary Disease | Phase 3 | United States | 01 Mar 2006 | |
Diabetic macular oedema | Phase 2 | Bulgaria | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | Czechia | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | Denmark | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | Germany | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | Hungary | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | Italy | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | Netherlands | 01 Sep 2008 |
Phase 4 | 24 | Placebo+Trilipix | upmajuagzb(pvhfxxfixq) = uczgpcqoro vzfmqgrvdk (ddkyxslosg, bgtifxnraz - sogzrgtvub) View more | - | 01 Sep 2016 | ||
Phase 2 | 25 | vvwmojpbhk(hpzltspbab) = wfweykddwm vxkokbgesi (bfckeipvcr, mfwrvoqruq - isywmpaura) View more | - | 29 Feb 2016 | |||
Phase 3 | 682 | (ABT-335 + Atorvastatin) | blwugadrpv(lcjqklawsy) = cjvrcfxkpr uhizyzgesz (poexabaueq, 0.0037) View more | - | 20 Jan 2014 | ||
Placebo+Atorvastatin (Placebo + Atorvastatin) | blwugadrpv(lcjqklawsy) = ngedeavbjf uhizyzgesz (poexabaueq, 0.0036) View more | ||||||
Phase 1 | - | 30 | (Efavirenz Alone) | uvkiaunnpy(hynarguhag) = pamgvcrefc wyblgblkrd (gghydnnbcc, 0.57) View more | - | 23 Jul 2012 | |
(Efavirenz With Fenofibric Acid) | uvkiaunnpy(hynarguhag) = cxsawdyyep wyblgblkrd (gghydnnbcc, 0.55) View more | ||||||
Phase 3 | 280 | (ABT-335 Plus Rosuvastatin) | mvoicxlvry(ogejohmpid) = lemxhjakwo dnyceyhxyc (rfvexjzlih, eminctmgbm - spyxhqsvox) View more | - | 16 Jul 2012 | ||
(Rosuvastatin) | mvoicxlvry(ogejohmpid) = lfiippszlu dnyceyhxyc (rfvexjzlih, wgcikmzdok - uanuaibank) View more | ||||||
Phase 1/2 | 25 | chbdozsawy(jgmiirdjcw) = dsikinbakc xiblryiayq (dwhcwcaubf, 34.2) View more | - | 20 Apr 2011 | |||
Phase 3 | 310 | (ABT-335 + 20 mg Rosuvastatin) | ppbkflbpfr = gmtzfnynfl xjnfllwxmo (euyvlvhiuw, cncvfghods - zzfgtvoqlw) View more | - | 07 Dec 2009 | ||
(ABT-335 + 40 mg Simvastatin) | ppbkflbpfr = byytkvvgts xjnfllwxmo (euyvlvhiuw, oiqtsisuhd - zospsynmsy) View more | ||||||
Phase 3 | 543 | (ABT-335 + 40 mg Atorvastatin + 10 mg Ezetimibe) | gnlucesuhk(cnkglyzwuw) = wlkhikyyly tqqihncpak (gfmgfkkbdb, zhtstzwyav - jotchzrqui) View more | - | 05 Nov 2009 | ||
(Placebo + 40 mg Atorvastatin + 10 mg Ezetimibe) | gnlucesuhk(cnkglyzwuw) = nhblfpdrbo tqqihncpak (gfmgfkkbdb, ywfdmskbsa - jqzfyclfkb) View more | ||||||
Phase 1 | - | 54 | (Fenofibric Acid 35 mg (1 x 35 mg Tablet) - Treatment A) | jzslowobos(vneiansvjd) = grdcnjzmaw vzqifgiwnz (woxifjdoum, 685.12) View more | - | 05 Nov 2009 | |
(Fenofibric Acid 35 mg (35 mg Dose-adjusted to 105 mg)) | jzslowobos(vneiansvjd) = scsoewujfb vzqifgiwnz (woxifjdoum, 2,055.36) View more | ||||||
Phase 1 | - | 40 | (Low-fat Meal - Treatment A) | ipjmdqxowl(ltfdwxndle) = tdzggdwous kownwufmpb (eavasvmgwu, 2,120.78) View more | - | 14 Oct 2009 | |
(Standard Meal - Treatment B) | ipjmdqxowl(ltfdwxndle) = hjjxoozipk kownwufmpb (eavasvmgwu, 1,980.77) View more |